Pentokey Organy (India) Limited (BOM:524210)
40.58
+4.53 (12.57%)
At close: Jun 2, 2026
Pentokey Organy (India) Revenue
In the fiscal year ending March 31, 2026, Pentokey Organy (India) had annual revenue of 24.98M INR with 202.34% growth. Pentokey Organy (India) had revenue of -16.87M in the quarter ending March 31, 2026.
Revenue
24.98M
Revenue Growth
+202.34%
P/S Ratio
10.19
Revenue / Employee
8.33M
Employees
3
Market Cap
254.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 24.98M | 16.72M | 202.34% |
| Mar 31, 2025 | 8.26M | -35.70M | -81.21% |
| Mar 31, 2024 | 43.96M | 308.00K | 0.71% |
| Mar 31, 2023 | 43.66M | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Centuple Global | 5.74B |
| Dipna Pharmachem | 1.07B |
| Medico Intercontinental | 853.55M |
| Medistep Healthcare | 708.54M |
| Constronics Infra | 503.25M |
| Chandra Bhagat Pharma | 493.95M |
| Zenlabs Ethica | 471.07M |
| Evoq Remedies | 407.29M |